Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $6,110 | 4 | 74.3% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $1,200 | 3 | 14.6% |
| Grant | $670.88 | 1 | 8.2% |
| Food and Beverage | $183.59 | 2 | 2.2% |
| Education | $61.20 | 1 | 0.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GlaxoSmithKline, LLC. | $4,160 | 3 | $0 (2023) |
| NOVARTIS PHARMACEUTICALS CORPORATION | $1,950 | 1 | $0 (2023) |
| F. Hoffmann-La Roche AG | $1,200 | 3 | $0 (2017) |
| GENZYME CORPORATION | $670.88 | 1 | $0 (2023) |
| Otsuka Pharmaceutical Co., Ltd. | $141.59 | 1 | $0 (2018) |
| Otsuka America Pharmaceutical, Inc. | $61.20 | 1 | $0 (2019) |
| Vertex Pharmaceuticals Incorporated | $42.00 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $3,963 | 4 | NOVARTIS PHARMACEUTICALS CORPORATION ($1,950) |
| 2022 | $2,860 | 2 | GlaxoSmithKline, LLC. ($2,860) |
| 2019 | $61.20 | 1 | Otsuka America Pharmaceutical, Inc. ($61.20) |
| 2018 | $141.59 | 1 | Otsuka Pharmaceutical Co., Ltd. ($141.59) |
| 2017 | $1,200 | 3 | F. Hoffmann-La Roche AG ($1,200) |
All Payment Transactions
11 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/13/2023 | GlaxoSmithKline, LLC. | BENLYSTA (Biological) | Consulting Fee | Cash or cash equivalent | $1,300.00 | General |
| Category: IMMUNOLOGY | ||||||
| 12/05/2023 | GENZYME CORPORATION | — | Grant | Cash or cash equivalent | $670.88 | General |
| 09/14/2023 | NOVARTIS PHARMACEUTICALS CORPORATION | — | Consulting Fee | Cash or cash equivalent | $1,950.00 | General |
| 08/31/2023 | Vertex Pharmaceuticals Incorporated | — | Food and Beverage | In-kind items and services | $42.00 | General |
| 08/02/2022 | GlaxoSmithKline, LLC. | BENLYSTA (Biological) | Consulting Fee | Cash or cash equivalent | $1,365.00 | General |
| Category: IMMUNOLOGY | ||||||
| 04/19/2022 | GlaxoSmithKline, LLC. | BENLYSTA (Biological) | Consulting Fee | Cash or cash equivalent | $1,494.95 | General |
| Category: IMMUNOLOGY | ||||||
| 06/19/2019 | Otsuka America Pharmaceutical, Inc. | SAMSCA (Drug) | Education | In-kind items and services | $61.20 | General |
| Category: NEPHROLOGY | ||||||
| 09/27/2018 | Otsuka Pharmaceutical Co., Ltd. | — | Food and Beverage | In-kind items and services | $141.59 | General |
| 06/30/2017 | F. Hoffmann-La Roche AG | Rituxan (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | In-kind items and services | $316.76 | General |
| Category: BioOncology/Immunology | ||||||
| 06/30/2017 | F. Hoffmann-La Roche AG | Rituxan (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | In-kind items and services | $174.35 | General |
| Category: BioOncology/Immunology | ||||||
| 03/31/2017 | F. Hoffmann-La Roche AG | Rituxan (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | In-kind items and services | $708.60 | General |
| Category: BioOncology/Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 97 | 190 | $64,685 | $13,661 |
| 2022 | 3 | 75 | 156 | $58,044 | $11,490 |
| 2021 | 4 | 94 | 232 | $81,890 | $18,842 |
| 2020 | 6 | 175 | 333 | $124,829 | $25,850 |
All Medicare Procedures & Services
17 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 34 | 70 | $25,415 | $6,372 | 25.1% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 34 | 78 | $19,726 | $4,731 | 24.0% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 16 | 16 | $7,568 | $1,584 | 20.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 13 | 26 | $11,976 | $973.31 | 8.1% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 44 | 112 | $38,940 | $8,736 | 22.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 19 | 32 | $13,636 | $1,533 | 11.2% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 12 | 12 | $5,468 | $1,222 | 22.3% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 48 | 173 | $60,515 | $14,072 | 23.3% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 17 | 28 | $10,318 | $2,214 | 21.5% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 15 | 16 | $7,388 | $1,707 | 23.1% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 14 | 15 | $3,669 | $848.40 | 23.1% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 82 | 225 | $91,017 | $18,754 | 20.6% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2020 | 22 | 22 | $11,361 | $2,418 | 21.3% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 31 | 39 | $11,108 | $2,263 | 20.4% |
| 99221 | Initial hospital inpatient care, typically 30 minutes per day | Facility | 2020 | 11 | 11 | $4,321 | $886.94 | 20.5% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Facility | 2020 | 18 | 24 | $5,344 | $769.53 | 14.4% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Facility | 2020 | 11 | 12 | $1,678 | $759.39 | 45.3% |
About Dr. Patrick Nachman, MD
Dr. Patrick Nachman, MD is a Nephrology healthcare provider based in Minneapolis, Minnesota. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/04/2006. The National Provider Identifier (NPI) number assigned to this provider is 1912075144.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Patrick Nachman, MD has received a total of $8,225 in payments from pharmaceutical and medical device companies, with $3,963 received in 2023. These payments were reported across 11 transactions from 7 companies. The most common payment nature is "Consulting Fee" ($6,110).
As a Medicare-enrolled provider, Nachman has provided services to 441 Medicare beneficiaries, totaling 911 services with total Medicare billing of $69,843. Data is available for 4 years (2020–2023), covering 17 distinct procedure/service records.
Practice Information
- Specialty Nephrology
- Other Specialties Nephrology
- Location Minneapolis, MN
- Active Since 12/04/2006
- Last Updated 11/21/2017
- Taxonomy Code 207RN0300X
- Entity Type Individual
- NPI Number 1912075144
Products in Payments
- BENLYSTA (Biological) $4,160
- Rituxan (Biological) $1,200
- SAMSCA (Drug) $61.20
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Nephrology Doctors in Minneapolis
Kirsten Johansen, Md, MD
Nephrology — Payments: $134,524
Dr. Jeffrey Kohen, M.d, M.D
Nephrology — Payments: $101,893
Dr. James Wetmore, Md, MD
Nephrology — Payments: $49,852
Dr. Robert Foley, Mb, MB
Nephrology — Payments: $27,301
Jeffrey Connaire, Md, MD
Nephrology — Payments: $15,134
Keith Eidman, Do, DO
Nephrology — Payments: $8,274